# GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
Canonical URL: https://biopharmsignal.com/news/GDRX/goodrx-launches-goodrx-companion-a-new-subscription-designed-to-lower-everyday-healthcare-costs
Ticker: GDRX
Company: GoodRx
Source: GoodRx
Published: 2026-06-25 13:46 EST
Original Source URL: https://investors.goodrx.com
## Summary

New $14.99 -per-month membership brings together free and low-cost generic medications, affordable online care visits, and savings across dental, vision, labs and imaging Brief Summary: GoodRx launched GoodRx Companion, a new $14.99 -per-month subscription to lower everyday healthcare costs

## Article Body
New $14.99 -per-month membership brings together free and low-cost generic medications, affordable online care visits, and savings across dental, vision, labs and imaging Brief Summary: GoodRx launched GoodRx Companion, a new $14.99 -per-month subscription to lower everyday healthcare costs
## Recent Company News
- 2026-06-25 13:46 EST — [GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs](https://biopharmsignal.com/news/GDRX/goodrx-launches-goodrx-companion-a-new-subscription-designed-to-lower-everyday-healthcare-costs) — Source: GoodRx
- 2026-06-25 13:46 EST — [GoodRx Reports First Quarter 2026 Results](https://biopharmsignal.com/news/GDRX/goodrx-reports-first-quarter-2026-results) — Source: GoodRx
- 2026-06-25 13:46 EST — [GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale](https://biopharmsignal.com/news/GDRX/goodrx-earns-hitrust-i1-certification-for-the-second-consecutive-year-reinforcing-its-commitment-to-protecting-healthcare-data-at-scale) — Source: GoodRx
- 2026-06-25 13:46 EST — [GoodRx Powers Pricing for Leading Brand Medications on TrumpRx](https://biopharmsignal.com/news/GDRX/goodrx-powers-pricing-for-leading-brand-medications-on-trumprx) — Source: GoodRx
- 2026-06-25 13:46 EST — [GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”](https://biopharmsignal.com/news/GDRX/goodrx-expands-into-employer-market-with-launch-of-goodrx-employer-direct) — Source: GoodRx
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)